Tsumura & Co.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSMRF research report →
About the company
Tsumura & Co. is a global pharmaceutical company specializing in the production and distribution of various medicinal products. Their core offerings include Kampo extract intermediates and granular Kampo formulations.
- CEO
- Terukazu Kato
- IPO
- 2013
- Employees
- 4,138
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $1.73B
- P/E
- 9.97
- P/S
- 1.45
- P/B
- 0.87
- EV/EBITDA
- 6.00
- Div Yield
- 3.91%
- Gross Margin
- 47.51%
- Op Margin
- 18.29%
- Net Margin
- 14.60%
- ROE
- 9.29%
- ROIC
- 4.97%
- Revenue
- $193.83B · 7.03%
- Net Income
- $28.29B · -12.75%
- EPS
- $378.68 · -11.35%
- Op Income
- $35.44B
- FCF YoY
- -301.36%
- 52W High
- $28.15
- 52W Low
- $23.20
- 50D MA
- $23.20
- 200D MA
- $23.20
- Beta
- 0.06
- Avg Volume
- 60.8
Get TickerSpark's AI analysis on TSMRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TSMRF coverage
Recent articles, reports, and earnings notes.
No research on TSMRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TSMRF report →Similar companies
Peers in the same neighborhood.